Sigyn Therapeutics (SIGY) Market Capitalization (2021 - 2025)

Sigyn Therapeutics has disclosed Market Capitalization across 5 years of filings, most recently posting $6.0 million for Q3 2025.

• In Q3 2025, Market Capitalization fell 26.3% year-over-year to $6.0 million; the TTM figure through Sep 2025 stood at $6.0 million (down 26.3% YoY), while the FY2024 annual figure was $4.2 million, down 30.98% from the prior year.
• Market Capitalization came in at $6.0 million for Q3 2025 at Sigyn Therapeutics, up from $4.4 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $2.8 billion in Q1 2021 to a low of $4.2 million in Q4 2024.
• Average Market Capitalization over 5 years is $464.3 million, with a median of $256.8 million recorded in 2023.
• Year-over-year, Market Capitalization soared 66.05% in 2023 and tumbled 98.35% in 2024.
• Over 5 years, Market Capitalization stood at $745.9 million in 2021, then tumbled by 65.12% to $260.2 million in 2022, then slumped by 97.66% to $6.1 million in 2023, then slumped by 30.98% to $4.2 million in 2024, then jumped by 43.43% to $6.0 million in 2025.
• Per Business Quant data, the three most recent Market Capitalization figures were $6.0 million in Q3 2025, $4.4 million in Q2 2025, and $6.7 million in Q1 2025.